Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The use of compounded medications involves known and unknown risks that vary from patient to patient
Subsequent elevations in NAD+ levels activate sirtuin 1 (SIRT1), a cellular regulatory enzyme dependent on NAD+ availability
Peptide protocols that include microneedling, laser therapy, or pharmaceutical treatments like minoxidil may show synergistic effects
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
For NNMT assays remember that the compound competes at the nicotinamide substrate site, so the apparent potency depends on the nicotinamide concentration used
US$ 27.06
US$ 23.96
US$ 24.99
US$ 29.38
US$ 20.01
US$ 29.87
US$ 28.87
US$ 29.16
